Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 2.87 AUD 1.77% Market Closed
Market Cap: 3.7B AUD

Wall Street
Price Targets

MSB Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MSB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MSB is 3.54 AUD with a low forecast of 3.14 AUD and a high forecast of 4.2 AUD.

Lowest
Price Target
3.14 AUD
9% Upside
Average
Price Target
3.54 AUD
23% Upside
Highest
Price Target
4.2 AUD
46% Upside
Mesoblast Ltd Competitors:
Price Targets
002252
Shanghai RAAS Blood Products Co Ltd
10% Upside
068270
Celltrion Inc
20% Upside
397030
AprilBio Co Ltd
16% Upside
BIOCON
Biocon Ltd
15% Upside
FOLD
Amicus Therapeutics Inc
71% Upside
ASND
Ascendis Pharma A/S
36% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
45% Upside
LGND
Ligand Pharmaceuticals Inc
31% Upside

Revenue
Forecast

Revenue Estimate
Mesoblast Ltd

For the last 13 years the compound annual growth rate for Mesoblast Ltd's revenue is -6%. The projected CAGR for the next 3 years is 178%.

-6%
Past Growth
178%
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Mesoblast Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MSB's stock price target?
Price Target
3.54 AUD

According to Wall Street analysts, the average 1-year price target for MSB is 3.54 AUD with a low forecast of 3.14 AUD and a high forecast of 4.2 AUD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
178%

For the last 13 years the compound annual growth rate for Mesoblast Ltd's revenue is -6%. The projected CAGR for the next 3 years is 178%.

Back to Top